Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.003x

Based on the latest financial reports, Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932) has a cash flow conversion efficiency ratio of 0.003x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥15.57 Million ≈ $2.28 Million USD) by net assets (CN¥5.73 Billion ≈ $838.11 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Wuhan Easy Diagnosis Biomedicine Co Ltd (002932) liquidity interval to measure how many days the company can operate on defensive assets alone.

Wuhan Easy Diagnosis Biomedicine Co Ltd Class A - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Wuhan Easy Diagnosis Biomedicine Co Ltd Class A's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Wuhan Easy Diagnosis Biomedicine Co Ltd Class A Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Wuhan Easy Diagnosis Biomedicine Co Ltd Class A ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Bank Maspion Indonesia PT JK:BMAS	0.015x
Chun Yuan Steel Industry Co Ltd TW:2010	0.019x
SNT Holdings Co Ltd KO:036530	-0.006x
Anhui Wantong Technology Co Ltd SHE:002331	-0.065x
Tianjin Pengling Rubber Hose Co Ltd SHE:300375	0.023x
Malibu Boats Inc NASDAQ:MBUU	0.025x
Relx PLC LSE:REL	0.608x
Lycopodium Ltd AU:LYL	0.128x

Annual Cash Flow Conversion Efficiency for Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (2011–2025)

The table below shows the annual cash flow conversion efficiency of Wuhan Easy Diagnosis Biomedicine Co Ltd Class A from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see 002932 stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥5.66 Billion ≈ $827.62 Million	CN¥-70.05 Million ≈ $-10.25 Million	-0.012x	+12.34%
2024-12-31	CN¥6.02 Billion ≈ $880.72 Million	CN¥-85.05 Million ≈ $-12.44 Million	-0.014x	-122.65%
2023-12-31	CN¥6.29 Billion ≈ $920.73 Million	CN¥392.50 Million ≈ $57.43 Million	0.062x	-89.47%
2022-12-31	CN¥6.77 Billion ≈ $990.93 Million	CN¥4.01 Billion ≈ $587.21 Million	0.593x	+49.86%
2021-12-31	CN¥2.85 Billion ≈ $417.06 Million	CN¥1.13 Billion ≈ $164.92 Million	0.395x	+22.57%
2020-12-31	CN¥1.11 Billion ≈ $163.14 Million	CN¥359.68 Million ≈ $52.63 Million	0.323x	+783.28%
2019-12-31	CN¥615.62 Million ≈ $90.08 Million	CN¥22.49 Million ≈ $3.29 Million	0.037x	-59.67%
2018-12-31	CN¥592.59 Million ≈ $86.72 Million	CN¥53.67 Million ≈ $7.85 Million	0.091x	-52.68%
2017-12-31	CN¥242.93 Million ≈ $35.55 Million	CN¥46.50 Million ≈ $6.80 Million	0.191x	-43.07%
2016-12-31	CN¥175.08 Million ≈ $25.62 Million	CN¥58.86 Million ≈ $8.61 Million	0.336x	-13.84%
2015-12-31	CN¥115.39 Million ≈ $16.89 Million	CN¥45.02 Million ≈ $6.59 Million	0.390x	+17.45%
2014-12-31	CN¥49.59 Million ≈ $7.26 Million	CN¥16.47 Million ≈ $2.41 Million	0.332x	-28.26%
2013-12-31	CN¥13.60 Million ≈ $1.99 Million	CN¥6.30 Million ≈ $921.32K	0.463x	-36.17%
2012-12-31	CN¥1.42 Million ≈ $208.28K	CN¥1.03 Million ≈ $151.10K	0.725x	+103.22%
2011-12-31	CN¥21.45K ≈ $3.14K	CN¥-482.90K ≈ $-70.66K	-22.514x	--

About Wuhan Easy Diagnosis Biomedicine Co Ltd Class A

SHE:002932 China Medical Devices

Market Cap

$506.97 Million

CN¥3.46 Billion CNY

Market Cap Rank

#12319 Global

#3605 in China

Share Price

CN¥14.90

Change (1 day)

+0.20%

52-Week Range

CN¥14.75 - CN¥22.86

All Time High

CN¥49.58